Elevance Health (ELV) Stock Statistics & Valuation Metrics

Elevance Health has a market cap or net worth of $89.39B. The enterprise value is $115.48B.

Market Cap

$89.39B

Enterprise Value

$115.48B

Elevance Health has 216,055,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

216,055,900

Owned by Insiders

0.17%

Owned by Institutions

59.42%

Elevance Health’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 6.65%.

Return on Equity (ROE)

0.13

Return on Assets (ROA)

0.05

Return on Invested Capital (ROIC)

6.65%

Return on Capital Employed (ROCE)

0.08

Revenue Per Employee

2.06M

Profits Per Employee

58.60K

Employee Count

96,615

Asset Turnover

1.64

Inventory Turnover

0.00

The current PE Ratio of Elevance Health is 18.40. Elevance Health’s PEG ratio is -4.34.

PE Ratio

18.40

PS Ratio

0.46

PB Ratio

2.10

Price to FCF

14.38

Price to Operating Cash Flow

12.38

PEG Ratio

-4.34

In the last 12 months, Elevance Health had revenue of 199.13B and earned 5.66B in profits. Earnings per share was 25.18.

Revenue

199.13B

Gross Profit

50.90B

Operating Income

8.11B

Pretax Income

6.71B

Net Income

5.66B

EBITDA

9.66B

Earnings Per Share (EPS)

25.18

In the last 12 months, operating cash flow was 7.60B and capital expenditures -1.08B, giving a free cash flow of 6.51B billion.

Operating Cash Flow

7.60B

Free Cash Flow

6.51B

Free Cash Flow per Share

29.94

Elevance Health pays an annual dividend of $1.72, resulting in a dividend yield of 1.58%

Dividend Per Share

$1.72

Dividend Yield

1.58%

Payout Ratio

23.34%

Free Cash Flow Yield

7.00%

Earnings Yield

5.50%

Beta

0.43

52-Week Price Change

35.81%

50-Day Moving Average

410.83

200-Day Moving Average

370.88

Relative Strength Index (RSI)

57.41

Average Volume (3m)

1.18M

Elevance Health upcoming earnings date is Jan 27, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 21, 2026

Next Earnings Date

Jan 27, 2027

Ex-Dividend Date

Sep 10, 2026

Elevance Health as a current ratio of 1.24, with Debt / Equity ratio of 75.74%

Current Ratio

1.24

Quick Ratio

1.24

Debt to Market Cap

0.42

Net Debt to EBITDA

2.46

Interest Coverage Ratio

5.79

In the past 12 months, Elevance Health has paid 1.05B in taxes.

Income Tax

1.05B

Effective Tax Rate

0.16

Elevance Health EV to EBITDA ratio is 12.78, with an EV/FCF ratio of 17.42.

EV to Sales

0.56

EV to EBITDA

12.78

EV to Free Cash Flow

17.42

EV to Operating Cash Flow

14.94

Elevance Health has $37.85B in cash and marketable securities with $30.76B in debt, giving a net cash position of $7.09B billion.

Cash & Marketable Securities

$37.85B

Total Debt

$30.76B

Net Cash

$7.09B

Net Cash Per Share

$32.81

Tangible Book Value Per Share

$25.62

Gross margin is 36.55%, with operating margin of 3.69%, and net profit margin of 2.55%.

Gross Margin

36.55%

Operating Margin

3.69%

Pretax Margin

3.10%

Net Profit Margin

2.55%

EBITDA Margin

4.40%

EBIT Margin

3.66%

The average price target for Elevance Health is $479.85, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

$479.85

Price Target Upside

11.08% Upside

Analyst Consensus

Moderate Buy

Analyst Count

14

Revenue Growth Forecast

3.60%

EPS Growth Forecast

-4.06%

Smart Score

5

AI Score

76